New Delhi: Drugs Controller General of India (DCGI) has given Cipla approval to import Moderna's COVID-19 vaccine for restricted emergency use in the country. Moderna’s COVID-19 vaccine will be ...
Cipla Limited has entered into a partnership with Premier Medical Corporation Private Limited for the commercialisation of the rapid antigen test kits to detect COVID 19 in India. The company ...
New Delhi: Leading pharmaceutical company Cipla has sought permission to launch Favipiravir, an anti-viral drug, in India to fight against COVID-19. Sources said the Council of Scientific and Industrial Research ...
Bengaluru: Indian drugmaker Cipla, has priced its generic version of Remdesivir, Cipremi at Rs 4,000 ($53.34) per 100 mg vial, making it among the lowest-priced versions of the COVID-19 treatment ...
New Delhi: Amid rising cases of coronavirus, there are reports about supply shortage and selling of two life-saving drugs — remdesivir and tocilizumab — for exorbitant rates on old Delhi's ...
Another anti-viral drug for the treatment of COVID-19 has been launched, this time by pharma major Cipla. To be sold in the market under the brand name of Cipremi, this ...
Copyright © 2025 Frontier Media
